Clinical Trial Update: Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sequential neo-adjuvant chemotherapy followed by capecitabine versus conventional adjuvant chemotherapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Breast Neoplasm Female | Phase 3 | Status: UNKNOWN